These success, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the idea of focusing on ACKR3 as a novel technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-simila